Abstract
Tumor invasion and metastasis are multistep processes which require extracellular matrix remodeling by proteolytic enzymes such as matrix metalloproteinases (MMPs). The production of these enzymes is stimulated by many soluble or cell-bound factors. Among these factors, extracellular matrix metalloproteinase inducer (EMMPRIN) is known to increase in vitro stromal cell production of MMP-1, MMP-2 and MMP-3. In this study, we demonstrated that EMMPRIN-transfected MDA-MB-436 tumor cells displayed a more invasive capacity than vector-transfected cells in a modified Boyden chamber invasion assay. Using gelatin zymography and protein analyses, we showed that EMMPRIN-transfected cancer cells produced significantly more latent and active MMP-2 and MMP-3 than vector-transfected cancer cells. We found that EMMPRIN did not regulate MMP-1, MMP-9, membrane type-1 MMP (MT1-MMP) expression and had also no effect on the production of the specific tissue inhibitors of MMPs (TIMPs), TIMP-1 and TIMP-2. We also demonstrated that tumor-derived EMMPRIN stimulated MMP-1, -2, and -3 without modification of MMP-9, MT1-MMP, TIMP-1 and TIMP-2 production in human umbilical vein endothelial cells (HUVEC). These data provide support for the role of EMMPRIN in tumor invasion, metastasis, and neoangiogenesis by stimulating extracellular matrix remodeling around tumor cell clusters, stroma, and blood vessels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ellerbroek SM, Stack MS. Membrane associated matrix metalloproteinases in metastasis. BioEssays 1999; 21: 940–9.
Curran S, Murray GI. Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 1999; 189: 300–8.
Ura H, Bonfil RD, Reich R et al. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic invasive and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 1989; 49: 4615–21.
Gilles C, Polette M, Piette J et al. Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer 1994; 59: 661–6.
Polette M, Gilles C, de Bentzmann S et al. Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines. Clin Exp Metast 1998; 16: 105–12.
Polette M, Birembaut P. Matrix expression in breast cancers. Breast J 1996; 2: 209–20.
Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 1999; 103: 1237–41.
Biswas C, Zhang Y, DeCastro R et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55: 434–9.
Kataoka H, DeCastro R, Zucker S et al. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 1993; 53: 3154–8.
Guo H, Zucker S, Gordon MK et al. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 1997; 1: 24–7.
Ellis SM, Nabeshima K, Biswas C. Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res 1989; 49: 3385–91.
Nabeshima K, Lane WS, Biswas C. Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys 1991; 285: 90–6.
Muraoka K, Nabeshima K, Murayama T et al. Enhanced expression of tumor-cell-derived collagenase-stimulatory factor in urothelium carcinomas: Its usefull as a tumor marker for bladder cancers. Int J Cancer 1993; 55: 19–26.
Van den Oord JJ, Paemen L, Opdenakker G et al. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 1997; 151: 665–70.
Caudroy S, Polette M, Tournier JM et al. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem 1999; 47: 1575–80.
Polette M, Gilles C, Marchand V et al. Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 1996; 45: 703–7.
Zucker S, Hymowitz M, Rollo EE et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001; 158: 1921–8.
Zucker S, Conner C, DiMassimo BI et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 1995; 270: 23730–8.
Zucker S, Mirza H, Conner CE et al. Vascular endothelial growth tissue factor and matrix metalloproteinases production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998, 75: 780–6.
Moutsiakis D, Mancuso P, Krutzsch H et al. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connective Tissue Res 1992; 28: 212–30.
Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/Extracellular Matrix Metalloproteinase Inducer interactions. Cancer Res 2001; 61: 2276–81.
Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of the 72 kD type IV collagenase: Isolation of the activate form of the membrane metalloproteinase. J Biol Chem 1995; 270: 5331–8.
Samehima T, Nabeshima K, Toole BP et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000; 157: 177–84.
Zucker S, Biswas C. Tumor collagenase stimulating factor: A paracrine stimulator of fibroblast production of matrix metalloproteinases in cancer. Bull Inst Pasteur 1994; 92: 284–90.
Bordador LC, Li XL, Toole B et al. Expression of EMMPRIN by oral squamous cell carcinomas. Int J Cancer 2000; 85: 347–52.
Guo H, Rongsong L, Zucker S et al. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000; 60: 888–91.
Schnaper HW, Grant DS, Stetler-Stevenson WG et al. Type IV collagenase( s) and TIMPs modulate endothelial cell morphologenesis in vitro. J Cell Physiol 1993; 156: 235–46.
Fischer C, Gilbertson-Beadling S, Powers EA et al. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994; 162: 499–510.
Hanemaaijer R, Koolwijk P, Le Clercq L et al. Regulation of matrix metalloproteinase expression in human vein microvascular endothelial cells. Biochem J 1993; 296: 803–9.
Taraboletti G, Garafola A, Belotti D et al. Inhibition of angiogenesis and murine hemangioma growth with batimastat, a synthetic inhibitor of metalloproteinases. J Natl Cancer Inst 1995; 87: 293–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caudroy, S., Polette, M., Nawrocki-Raby, B. et al. EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 19, 697–702 (2002). https://doi.org/10.1023/A:1021350718226
Issue Date:
DOI: https://doi.org/10.1023/A:1021350718226